Diagnostic imaging market seen reaching $134.75 billion by 2035

Market Research Future projects the global diagnostic imaging market will rise from $84.40 billion in 2025 to $134.75 billion by 2035, supported by aging populations, screening mandates and wider use of AI in radiology. The forecast points to faster growth in CT, software and outpatient imaging as providers modernize equipment and expand access.

Why it matters: - The diagnostic imaging market is moving from a hardware-led category to a broader clinical infrastructure market tied to cancer screening, chronic disease management and outpatient care. - Rising demand from older populations and government-backed screening programs should keep imaging volumes growing through 2035. - AI and photon-counting CT are changing scan speed, dose and workflow economics, which could reshape purchasing decisions across hospitals and imaging centers.

What happened: - Market Research Future estimated the global diagnostic imaging market at $84.40 billion in 2025. - The market is projected to reach $134.75 billion by 2035. - The forecast implies a 4.80% CAGR from 2026 to 2035. - From a 2026 starting value of $88.41 billion, the market is set for steady expansion.

The details: - The aging population is a major demand driver. The World Health Organization estimates adults 65 and older will double to 1.6 billion globally by 2050. - The same demographic shift is expected to lift demand for cancer, cardiovascular and neurological imaging. - In the United States, CMS projects Medicare imaging expenditures will grow 6% to 8% annually through 2030. - Government screening policy is also supporting demand. The European Commission’s Beating Cancer Plan targets 90% breast-screening coverage by 2025. - CMS reimbursement expansions for low-dose CT lung screening are also helping support utilization. - The FDA had cleared more than 900 AI-enabled medical-device algorithms as of early 2025, with radiology accounting for roughly 75% of those clearances. - Deep-learning reconstruction can cut MRI scan times by up to 50% and reduce CT noise by 40%. - AI-assisted triage can shorten critical-finding turnaround by 30 to 45 minutes. - Photon-counting CT is emerging as a key platform shift because it captures spectral energy data in a single acquisition. - Key OEMs spent more than $1.2 billion combined on R&D for photon-counting CT between 2022 and 2025. - The technology is forecast to lift CT modality revenue at a 6.8% CAGR through 2035. - X-ray was the largest modality in 2025 with a 27.1% share. - Computed tomography is the fastest-growing modality at a 6.8% CAGR. - MRI is projected to surpass $22.50 billion by 2035. - Diagnostic imaging was the largest application segment in 2025 with a 62.1% share. - Therapeutic and interventional imaging is the fastest-growing application at 7.1% CAGR. - Hospitals remained the largest end-user segment in 2025 with a 57.2% share. - Diagnostic imaging centers are the fastest-growing end-user segment at 7.6% CAGR. - Standalone imaging systems remain the dominant product type. - Software solutions are the fastest-growing product segment, driven by AI decision support, cloud PACS platforms and image analytics. - Mobile imaging systems are opening lower-cost screening use cases in emerging markets, including handheld ultrasound devices priced below $5,000.

Between the lines: - The market forecast points to a shift from one-time equipment sales toward recurring software, workflow and service revenue. - Photon-counting CT and AI-enabled reconstruction suggest vendors are competing on performance per scan, not just installed base. - Screening mandates and reimbursement changes matter because they create predictable demand, not just episodic upgrades. - The competitive field appears moderately concentrated, with the top five companies expected to hold a combined 55% to 65% revenue share. - GE HealthCare is estimated to hold 14% to 18% of revenue share. - Siemens Healthineers is estimated at 14% to 17% share. - Philips Healthcare is estimated at 10% to 13% share. - Fujifilm Healthcare is estimated at 5% to 8% share.

What's next: - North America is expected to remain the largest regional market, with 44.9% of global revenue in 2025. - Europe held 23.5% of the market in 2025, supported by procurement programs and dose-reduction policies. - Asia-Pacific is the fastest-growing region at 5.9% CAGR, helped by hospital upgrades in China and digital health expansion in India. - South America and the Middle East and Africa remain smaller but offer growth from public investment, PPP hospital projects and mobile imaging deployment. - The next competitive phase is likely to center on AI software subscriptions, managed-equipment service models, cloud analytics and greener imaging systems. - Market Research Future provided sample and customization links for the full report, including Request a free sample, Customize this report and Read the detailed insights.

The bottom line: - Diagnostic imaging is set for durable growth as demographics, screening policy and AI adoption combine to expand demand across hospitals, imaging centers and software-enabled workflows.